Karoon Energy Limited

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Acumen Pharmaceuticals faces strategic reset with $78.6m cash after Alzheimer’s drug failure

NRx Pharmaceuticals moves toward ketamine sales after FDA approval of domestic injectable product

Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?

Affle 3i to acquire Perion for $420m, but its $228m cash balance changes the deal maths

Business News Today infographic showing Karoon Energy Limited’s reduced 2026 Baúna production guidance after an electrical fault at the SPS-92 subsea well in Brazil, highlighting the lower output range, deferred production and higher unit-cost impact.

Karoon Energy (ASX: KAR) cuts Baúna guidance after new SPS-92 fault defers 3,500 barrels a day

Karoon Energy Limited has reduced 2026 production guidance for its Baúna Project after another electrical fault at the SPS-92 well forced output to be curtailed, deferring roughly 3,500 barrels a day and increasing unit-cost expectations.

byVenkatesh

October 2, 2026

Representative image of a deepwater oil platform offshore Nigeria as Exxon Mobil Corporation advances the $1 billion Usan Infill Project to add new crude production.

Karoon Energy (ASX: KAR) shares fell 28% in a month. Can 22,000 barrels a day from Baúna power a recovery?

Karoon has restored every Baúna well, but Who Dat delays and Brazil’s export tax still weigh. Can stronger second-half cash flow revive ASX: KAR?

byVenkatesh

July 13, 2026

The Latest

Acumen Pharmaceuticals faces strategic reset with $78.6m cash after Alzheimer’s drug failure

NRx Pharmaceuticals moves toward ketamine sales after FDA approval of domestic injectable product

Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?

Affle 3i to acquire Perion for $420m, but its $228m cash balance changes the deal maths

Karoon Energy (ASX: KAR) cuts Baúna guidance after new SPS-92 fault defers 3,500 barrels a day

Karoon Energy (ASX: KAR) shares fell 28% in a month. Can 22,000 barrels a day from Baúna power a recovery?

Acumen Pharmaceuticals faces strategic reset with $78.6m cash after Alzheimer’s drug failure

NRx Pharmaceuticals moves toward ketamine sales after FDA approval of domestic injectable product

Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?

Affle 3i to acquire Perion for $420m, but its $228m cash balance changes the deal maths

SAMILBIO expands Chaeyun skincare with two November launches as K-beauty exports reach $11.1bn

Schneider Electric Infrastructure (SCHNEIDER) shares fall 3.5% despite new factory expansion: What will November results reveal?

Haleon (HLN) near 319p: Does a 15% share-price crash make its valuation attractive after the growth downgrade?

Ethan Allen will split CEO and chair roles, but who gets to choose Farooq Kathwari’s successor?